Literature DB >> 23306001

Dolutegravir for treatment of HIV: SPRING forwards?

Laura J Waters1, Tristan J Barber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23306001     DOI: 10.1016/S0140-6736(12)62004-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Virologic Failure Among People Living With HIV Initiating Dolutegravir-Based Versus Other Recommended Regimens in Real-World Clinical Care Settings.

Authors:  Robin M Nance; Vani Vannappagari; Kimberly Smith; Catherine B Johannes; Brian Calingaert; Catherine W Saltus; Kenneth H Mayer; Bridget M Whitney; Benigno Rodriguez; Richard D Moore; Joseph J Eron; Elvin Geng; William Christopher Mathews; Michael J Mugavero; Michael S Saag; Mari M Kitahata; Joseph A C Delaney; Heidi M Crane
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-15       Impact factor: 3.731

2.  Biochemical analysis of the role of G118R-linked dolutegravir drug resistance substitutions in HIV-1 integrase.

Authors:  Peter K Quashie; Thibault Mesplède; Ying-Shan Han; Tamar Veres; Nathan Osman; Said Hassounah; Richard D Sloan; Hong-Tao Xu; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2013-09-30       Impact factor: 5.191

Review 3.  Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence.

Authors:  Thibault Mesplède; Mark A Wainberg
Journal:  Viruses       Date:  2015-07-07       Impact factor: 5.048

4.  Integrase Strand Transfer Inhibitors in HIV Therapy.

Authors:  Thibault Mesplède; Mark A Wainberg
Journal:  Infect Dis Ther       Date:  2013-11-19

5.  Classification and Design of HIV-1 Integrase Inhibitors Based on Machine Learning.

Authors:  Junlin Zhou; Juan Hao; Lianxin Peng; Huaichuan Duan; Qing Luo; Hailian Yan; Hua Wan; Yichen Hu; Li Liang; Zhenjian Xie; Wei Liu; Gang Zhao; Jianping Hu
Journal:  Comput Math Methods Med       Date:  2021-04-01       Impact factor: 2.238

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.